Schizophrenia

Neuroleptic malignant syndrome associated with clozapine treatment.

Tsai G, Crisostomo G, Rosenblatt ML, Stern TA. Neuroleptic malignant syndrome associated with clozapine treatment. Ann Clin Psychiatry. 1995;7(2):91-5. PubMed PMID: 8556099.

Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.

Li W, Ghose S, Gleason K, Begovic A, Perez J, Bartko J, et al. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry. 2015;172(4):373-82. DOI: 10.1176/appi.ajp.2014.14010123. PubMed PMID: 25585032.

Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder.

Byrne EM, Raheja UK, Stephens SH, Heath AC, Madden PAF, Vaswani D, et al. Seasonality shows evidence for polygenic architecture and genetic correlation with schizophrenia and bipolar disorder. J Clin Psychiatry. 2015;76(2):128-34. DOI: 10.4088/JCP.14m08981. PubMed PMID: 25562672.

Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.

Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry. 2015;172(1):17-31. DOI: 10.1176/appi.ajp.2014.13121691. PubMed PMID: 25553496.

Clinical correlates of clozapine prescription for schizophrenia in China.

Xiang Y-T, Weng Y-Z, Leung C-M, Tang W-K, Ungvari GS. Clinical correlates of clozapine prescription for schizophrenia in China. Hum. Psychopharmacol. Clin. Exp. 2007;22(1):17-25. DOI: 10.1002/hup.821. PubMed PMID: 17191268.

Real-world antipsychotic treatment practices.

Moore TA, Covell NH, Essock SM, Miller AL. Real-world antipsychotic treatment practices. Psychiatric Clin North Am. 2007;30(3):401-16. DOI: 10.1016/j.psc.2007.04.008. PubMed PMID: 17720029.

Clozapine resistance: augmentation strategies.

Porcelli S, Balzarro B, Serretti A. Clozapine resistance: augmentation strategies. European Neuropsychopharmacol. 2012;22(3):165-82. DOI: 10.1016/j.euroneuro.2011.08.005. PubMed PMID: 21906915.

A systematic review of the prevalence of schizophrenia.

Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. Plos Med. 2005;2(5):e141. DOI: 10.1371/journal.pmed.0020141. PubMed PMID: 15916472; PubMed Central PMCID: PMC1140952.

Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.

Lieberman JA. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J Clin Psychiatry. 1999;60 Suppl 12:9-12. PubMed PMID: 10372603.

Management of treatment resistance in schizophrenia.

Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry. 2001;50(11):898-911. PubMed PMID: 11743944.